Harbin Medisan Pharmaceutical Co., Ltd.
SHZ: 002900.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jian Fei Qin
- Employees
- 2,522
- Headquarters
- Harbin, China
- IPO year
- 2017
- Market cap
- CN¥3.7B
- Website
- https://www.medisan.com.cn
Loading 002900…
Loading profile data…Frequently asked questions about 002900
What does Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) do?
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical pharmaceutical dosage forms and APIs in China. It offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, body fluid balance infusion, and other medical...
Where does 002900.SZ trade?
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002900.SZ in?
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Harbin Medisan Pharmaceutical Co., Ltd.?
Jian Fei Qin is the chief executive officer of Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ).
Where is Harbin Medisan Pharmaceutical Co., Ltd. headquartered?
Harbin Medisan Pharmaceutical Co., Ltd. is headquartered in China.
Does 002900.SZ pay a dividend?
Yes — Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002900.SZ go public?
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) completed its initial public offering in 2017.